Tarriff Scott

CEO, Director, 10% OwnerEAGLE PHARMACEUTICALS, INC. (EGRX) · full profile →Form 4 · filed May 15, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$931K
Net Open-Market Flow
-$931K
Transactions
5
5 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 15, 2023Sell(S)200$21.52$4K1.6M
May 15, 2023Sell(S)15K$21.06$312K1.6M
May 12, 2023Sell(S)12K$20.42$242K1.6M
May 12, 2023Sell(S)3K$19.69$62K1.6M
May 11, 2023Sell(S)15K$20.71$311K1.6M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-029625) within minutes of acceptance. Every field above traces to the original document. Verify it directly: